Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:

  • 2024 Wells Fargo Healthcare Conference, Boston, September 4-6Sijmen de Vries, Chief Executive Officer, will participate in a fireside chat question and answer session on Friday, September 6 at 08:45 AM ET/14:45 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
  • H.C. Wainwright 26th Annual Global Investment Conference, New York, September 9-11Sijmen de Vries, Chief Executive Officer, will present on Monday, September 9 at 10:30 AM ET/16:30 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Wells Fargo or H.C. Wainwright representative.

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:

Pharming Group, Leiden, the NetherlandsMichael Levitan, VP Investor Relations & Corporate CommunicationsT: +1 (908) 705 1696E: investor@pharming.com

FTI Consulting, London, United KingdomVictoria Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the NetherlandsLeon MelensT: +31 6 53 81 64 27E: pharming@lifespring.nl

Attachment

  • Pharming attending Investor Conferences September 2024_EN_2SEP24
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Pharming Group NV Charts.
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Pharming Group NV Charts.